首页 › 基金 › CAPITAL MANAGEMENT CORP /VA › EXEL
CAPITAL MANAGEMENT CORP /VA 对 EXEL 的持仓历史
EXELIXIS INC · 医疗保健
CAPITAL MANAGEMENT CORP /VA 在 Q3 2026 的 13F 申报中披露持有 EXEL(EXELIXIS INC)158,325 股,市值约 US$9.2M,约占其申报组合的 1.39%,在其申报持仓中市值排名第 31 位。 CAPITAL MANAGEMENT CORP /VA 最近 13 个申报季度中有 13 个季度披露了 EXEL 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
CAPITAL MANAGEMENT CORP /VA 对 EXEL 的持仓演变
CAPITAL MANAGEMENT CORP /VA 于 Q3 2023 首次披露 EXEL 持仓:364,684 股(约 US$8.0M)。 该持仓在 Q4 2024 达到峰值 334,045 股,市值约 US$11.1M。 在 13 次申报中,CAPITAL MANAGEMENT CORP /VA 4 次增持、7 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 158,325 股、市值约 US$9.2M,环比减持 -2,995 股。。 持仓曾出现大幅变动:Q2 2024 减持约 26% (随后一个季度股价上涨 16%)、Q2 2025 减持约 29% (随后一个季度股价下跌 6%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 364.68K | $7.97M | 新进 |
| Q4 2023 | 391.60K | $9.39M | 增持 |
| Q1 2024 | 459.78K | $10.91M | 增持 |
| Q2 2024 | 339.92K | $7.64M | 减持 |
| Q3 2024 | 365.27K | $9.48M | 增持 |
| Q4 2024 | 334.05K | $11.12M | 减持 |
| Q1 2025 | 259.61K | $9.58M | 减持 |
| Q2 2025 | 183.30K | $8.08M | 减持 |
| Q3 2025 | 182.55K | $7.54M | 持有 |
| Q4 2025 | 184.97K | $8.11M | 增持 |
| Q1 2026 | 165.09K | $7.08M | 减持 |
| Q2 2026 | 161.32K | $8.78M | 减持 |
| Q3 2026 | 158.32K | $9.25M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 EXEL 与 13F 数据
EXEL(EXELIXIS INC)属于医疗保健行业。我们追踪的基金中还有 41 只申报持有 EXEL,申报仓位最大的包括:文艺复兴科技 (US$747.2M), 法拉龙资本管理 (US$732.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$732.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 EXEL 的基金
- 文艺复兴科技 12.79M 股 · $747.22M · Q3 2026
- 法拉龙资本管理 13.47M 股 · $732.79M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.47M 股 · $732.79M · Q2 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 8.93M 股 · $485.85M · Q2 2026
- D. E. Shaw & Co., Inc. 5.55M 股 · $302.07M · Q2 2026
- 双西格玛投资 4.21M 股 · $229.06M · Q2 2026
- Stephens Investment Management Group LLC 2.60M 股 · $151.65M · Q3 2026
- Caligan Partners LP 1.55M 股 · $84.51M · Q2 2026
更多关于 CAPITAL MANAGEMENT CORP /VA
常见问题
How long has CAPITAL MANAGEMENT CORP /VA held EXEL?
CAPITAL MANAGEMENT CORP /VA has disclosed EXEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is CAPITAL MANAGEMENT CORP /VA's current position in EXEL?
As of Q3 2026, CAPITAL MANAGEMENT CORP /VA holds 158.32K shares of EXEL (EXELIXIS INC), valued at $9.25M, representing 1.39% of its reported portfolio and ranking #31.
Has CAPITAL MANAGEMENT CORP /VA been buying or selling EXEL?
In the latest 13F filing (Q3 2026), CAPITAL MANAGEMENT CORP /VA reduced its position in EXEL. The position peaked in Q4 2024 at 334.05K shares.
Which other funds hold EXEL?
Other major institutional holders of EXEL include 文艺复兴科技, 法拉龙资本管理, FARALLON CAPITAL MANAGEMENT, L.L.C., among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.